Found: 6
Select item for more details and to access through your institution.
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 1121, doi. 10.1007/s00259-023-06467-y
- By:
- Publication type:
- Article
Influence of lanreotide on uptake of <sup>68</sup>Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 696, doi. 10.1007/s00259-018-4117-x
- By:
- Publication type:
- Article
Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00770-1
- By:
- Publication type:
- Article
Defining disease status in gastroenteropancreatic neuroendocrine tumors: Choi-criteria or RECIST?
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 3, p. 1071, doi. 10.1007/s00261-021-03393-1
- By:
- Publication type:
- Article
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma.
- Published in:
- 2005
- By:
- Publication type:
- journal article